Agios Pharmaceuticals | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 64.53B 4.19B 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 956K 2025-06
Amgen USD 53.76B 253M 2025-06
Arrowhead Research USD 200.33M 8.59M 2025-06
Astellas Pharma JPY 558.08B 6.82B 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Bayer EUR 31.71B 3.31B 2025-06
Biogen USD 6.28B 1.74B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Daiichi Sankyo JPY 100.84B 96M 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Exelixis USD 0 0 2025-04
Gilead Sciences USD 22.14B 6M 2025-06
GlaxoSmithKline GBP 15.3B 1.17B 2025-06
Incyte USD 31.76M 883K 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
Merck USD 33.97B 484M 2025-06
Moderna USD 32M 3M 2025-06
Novartis USD 24.06B 2.4B 2025-06
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.5B 137M 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
Sarepta Therapeutics USD 1.14B 1.17M 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


Agios Pharmaceuticals Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.